AliveCor was founded in 2010 by David Albert, Bruce Satchwell, and Kim Barnett. AliveCor has not officially endorsed a plan to participate in an IPO.
AliveCor is a developer of AI-powered personal electrocardiogram (ECG) technology. Per Forge data, AliveCor raised $154.3 million in funding over 9 rounds. Their latest funding was raised on Aug 16, 2022, from a Series F round. Key investors include Khosla Ventures, Bold Capital Ventures, Omron Healthcare, and GE Healthcare.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/16/2022 | Series F | $150MM | $xx.xx | $943.68MM | GE Healthcare, NGK-NTK, Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, WP Global Partners | |
Price per Share
$xx.xx
Shares Outstanding
10,192,501
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
GE Healthcare, NGK-NTK, Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, WP Global Partners
|
||||||
11/16/2020 | Series E | $65MM | $xx.xx | $449.94MM | OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures, Bold Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
6,688,757
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures, Bold Capital Partners
|
||||||
03/16/2017 | Series D | $30.08MM | $xx.xx | $173.09MM | OMRON, Mayo Clinic | |
Price per Share
$xx.xx
Shares Outstanding
6,147,014
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMRON, Mayo Clinic
|
||||||
03/31/2016 | Series C-2 | $5.74MM | $xx.xx | $88.15MM | WP Global Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,862,235
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
WP Global Partners
|
||||||
03/31/2016 | Series C-1 | $5.14MM | $xx.xx | $88.15MM | WP Global Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,477,081
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
WP Global Partners
|
||||||
03/31/2016 | Series C | $8.03MM | $xx.xx | $88.15MM | WP Global Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,082,197
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
WP Global Partners
|
||||||
06/11/2012 | Series B-1 | $10.5MM | $xx.xx | $52.63MM | Khosla Ventures, Qualcomm Ventures, Oklahoma Life Sciences Fund, Bold Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,049,474
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Khosla Ventures, Qualcomm Ventures, Oklahoma Life Sciences Fund, Bold Capital Partners
|
||||||
08/23/2011 | Series A-1 | $2.64MM | $xx.xx | $13.22MM | Qualcomm Ventures, Oklahoma Life Sciences Fund, Burrill & Company | |
Price per Share
$xx.xx
Shares Outstanding
528,730
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Qualcomm Ventures, Oklahoma Life Sciences Fund, Burrill & Company
|